Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Crohn'S & Colitis|April 13, 2017
Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised TrialAntonio López-Sanromán, Isabel Vera-Mendoza, Eugeni Domènech, et al.
Trials|November 16, 2021
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trialBerta Grau-Pujol, Daniel Camprubí-Ferrer, Helena Marti-Soler, et al.
Plos Neglected Tropical Diseases|July 13, 2023
Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvementPedro Laynez-Roldán, Irene Losada-Galván, Elizabeth Posada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 6, 2022
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk FactorsJuan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDACarla J Gargallo-Puyuelo, Elena Ricart, Eva Iglesias, et al.
Medicina (Kaunas, Lithuania)|December 31, 2025
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort StudyLuis G Guijarro, Patricia de Castro-Martínez, María Chaparro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2026
Time trends in strategies for postoperative Crohn's disease management and long-term surgical recurrence: ENEIDA registry dataGisela Piñero, Míriam Mañosa, Guillermo Bastida, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 20, 2016
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agentMaría Del Carmen R-Grau, María Chaparro, Francisco Mesonero, et al.
Inflammatory Bowel Diseases|May 14, 2013
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patientsMaría Chaparro, Ingrid Ordás, Eduard Cabré, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2026
Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumabPatricia de Castro-Martínez, Luis G Guijarro, Jorge Monserrat, et al.
Pageof 10